Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR TEST SYSTEMS executive Alistair N. Sporck reported updated holdings of company stock. A Form 4 entry shows 341 shares of Common Stock were withheld at $83.86 per share to satisfy tax obligations upon the vesting of restricted stock units, which the footnote clarifies is not an open-market sale.
After this tax-withholding transaction, Sporck directly holds 20,294 shares of Common Stock, and an additional 7,177 shares are held indirectly through a trust. The disclosed direct holdings figure also includes shares underlying unvested restricted stock units.
Aehr Test Systems completed sales under its at-the-market equity offering program, generating aggregate gross proceeds of approximately $60.0 million from common stock issuances. The shares were sold under an effective Form S-3 shelf registration that registered up to $100.0 million of securities, using a prospectus supplement dated April 8, 2026.
Aehr Test Systems executive Vernon Rogers sold 2,431 shares of Common Stock in an open-market transaction at $90.00 per share. After this sale, he directly holds 159,202 shares. A footnote explains that this remaining amount includes shares underlying unvested restricted stock units.
AEHR TEST SYSTEMS director Rhea J. Posedel reported an open-market sale of 7,500 shares of Common Stock at $88.09 per share through a trust. After this indirect transaction, the trust holds 396,979 shares. A separate entry shows 71,163 shares held directly, which includes shares subject to unvested restricted stock units.
AEHR Corporation affiliate reported multiple common‑stock dispositions. Rhea J. Posedel reported proposed and completed sales of Common shares under Form 144. The excerpt lists sales on 04/17/2026 (7,500 shares for $615,000), 04/16/2026 (15,000 shares for $1,210,800), 04/09/2026 (30,000 shares for $2,100,000) and 02/13/2026 (13,998 shares for $420,151.36). The filing also shows 7,500 shares listed as securities to be sold from a compensation grant dated 10/20/2020.
AEHR reported proposed and recent open-market sales of common stock on a Form 144 notice. The filing lists a proposed transfer tied to compensation dated 04/03/2026 and three completed sales by Vernon Rogers: 10,888 shares on 04/10/2026 for $762,160, 5,000 shares on 04/16/2026 for $434,400, and 5,000 shares on 04/20/2026 for $450,000.
AEHR Industries filed a Form 144 reporting proposed/resale and recent sales activity in its common stock. The filing lists multiple restricted stock vesting events in 2024 (examples: 1,535 shares on 07/14/2024, 899 shares on 10/11/2024) and shows recent sales by Vernon I. Rogers: 10,888 shares on 04/10/2026 for $762,160.00 and 20,000 shares on 04/16/2026 for $1,645,143.50. The filing also lists a broker entry with 5,000 shares and $450,000.00 referenced under securities information.
Aehr Test Systems director Fariba Danesh exercised options and sold shares in a linked transaction. Danesh exercised 8,000 Non-Qualified Options for Common Stock at $2.25 per share, then sold 8,000 Common shares at an average price of $82.63 on the same date.
After these transactions, Danesh directly holds 13,143 Common shares, and the reported amount includes shares subject to unvested restricted stock units. No derivative options remain from this specific grant following the exercise.
AEHR Test Systems director Rhea J. Posedel reported an open-market sale of 7,500 shares of Common Stock on April 17, 2026 at $82.00 per share, executed through an account held indirectly "By Trust". After this transaction, the trust still holds 404,479 shares, and Posedel also reports 71,163 shares held directly. A footnote notes that these reported amounts include shares subject to unvested restricted stock units.